Portfolio Building Block World Pharma and Biotech Index ETF (PBPH)
NASDAQ: PBPH · Real-Time Price · USD
25.81
+0.12 (0.47%)
Jun 5, 2026, 4:00 PM EDT - Market closed
PBPH Holdings Information
PBPH is an equity ETF with a total of 56 individual holdings. The top holdings are Eli Lilly and Company stock at 14.99%, Johnson & Johnson at 8.96%, AbbVie at 6.35%, Merck & Co. at 4.76%, and Roche Holding AG at 4.55%.
Total Holdings
56
Top 10 Percentage
60.76%
Asset Class
Equity
ETF Category
Health
Assets
765.47M
PE Ratio
19.65
Breakdown by Sector
Top 25 Holdings
| No. | Symbol | Name | % Weight |
|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 14.99% |
| 2 | JNJ | Johnson & Johnson | 8.96% |
| 3 | ABBV | AbbVie Inc. | 6.35% |
| 4 | MRK | Merck & Co., Inc. | 4.76% |
| 5 | SWX: ROP | Roche Holding AG | 4.55% |
| 6 | SWX: NOVN | Novartis AG | 4.52% |
| 7 | LON: AZN | AstraZeneca PLC | 4.34% |
| 8 | AMGN | Amgen Inc. | 4.20% |
| 9 | GILD | Gilead Sciences, Inc. | 4.20% |
| 10 | PFE | Pfizer Inc. | 3.87% |
| 11 | CPH: NOVO.B | Novo Nordisk A/S | 3.65% |
| 12 | BMY | Bristol-Myers Squibb Company | 2.96% |
| 13 | VRTX | Vertex Pharmaceuticals Incorporated | 2.86% |
| 14 | EPA: SAN | Sanofi | 2.47% |
| 15 | LON: GSK | GSK plc | 2.43% |
| 16 | REGN | Regeneron Pharmaceuticals, Inc. | 1.63% |
| 17 | EBR: ARGX | argenx SE | 1.31% |
| 18 | TYO: 4502 | Takeda Pharmaceutical Company Limited | 1.24% |
| 19 | ETR: BAYN | Bayer Aktiengesellschaft | 1.04% |
| 20 | ALNY | Alnylam Pharmaceuticals, Inc. | 1.00% |
| 21 | TLV: TEVA | Teva Pharmaceutical Industries Limited | 0.99% |
| 22 | ASX: CSL | CSL Limited | 0.97% |
| 23 | EBR: UCB | UCB SA | 0.91% |
| 24 | SWX: SDZ | Sandoz Group AG | 0.86% |
| 25 | ZTS | Zoetis Inc. | 0.85% |
As of Jun 2, 2026